Loading…
CSPC 2021 has ended
Back To Schedule
Tuesday, November 23 • 4:30pm - 6:00pm
307: Building Canada’s Biomanufacturing Capacity: An Ecosystem Approach Fit for Purpose

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Organized by: BioCanRx - Canada's Immunotherapy Network

The COVID-19 pandemic painfully highlighted the gaps in Canada’s domestic biomanufacturing capacity. In response, the Federal Government has made key investments to build up Canadian capacity. While these investments are essential, building structures in which to carry out GMP biomanufacturing are only one part of a very complex equation. The 2021 Biomanufacturing and Life Science Strategy recognizes this complexity and proposes a ‘strong coordinated structure for biomanufacturing and life science’ to maximize benefit to Canadians. The panel will discuss an ecosystem approach focused on the how to build and sustain a robust, interconnected biomanufacturing ecosystem with built-in resiliency and future pandemic readiness. 
Moderators
avatar for Karimah Es Sabar

Karimah Es Sabar

Chief Executive Officer & Partner, Quark Venture
Karimah Es Sabar is a highly-recognized Canadian life sciences leader with global experience and a successful career spanning multi-national pharmaceutical/biotechnology companies, startups, not-for-profit organizations and venture investment firms. She has provided leadership in... Read More →

Speakers
avatar for Dr. John Bell

Dr. John Bell

Senior Scientist, The Ottawa Hospital | Professor, Depts. Of Medicine and Biochemistry, Microbiology and Immunology, University of Ottawa | Scientific Director, BioCanRx | Director, Canadian Oncolytic Virus Consortium, PhD
He/himDr. John Bell is a world-renowned thought leader in oncolytic virus research and development. In addition to his many academic contributions to the field, Dr. Bell established a GMP manufacturing program that has produced clinical grade oncolytic viruses for worldwide use in... Read More →
avatar for Jennifer Quizi

Jennifer Quizi

Director of Biotherapeutics Manufacturing Operations, BioCanRx
Dr. Jennifer Quizi is Director of Biotherapeutics Manufacturing Operations at BioCanRx, and Director of the Biotherapeutics Manufacturing Centre - Virus Manufacturing Facility at the Ottawa Hospital. Previously within BioCanRx, Dr. Quizi held the position of Director of Scientific... Read More →
avatar for John D. Lewis

John D. Lewis

Founder, President and Chief Executive Officer, Entos
Dr. Lewis is the founder and CEO of Entos pharmaceuticals, a start-up Drug Delivery Company incorporated in 2017. He has a long track record of success leading biotechnology companies in the therapeutic and diagnostic spaces. In addition to his entrepreneurship, Dr. Lewis is the Frank... Read More →
avatar for Lakshmi Krishnan

Lakshmi Krishnan

Vice-president Of Life Sciences, National Research Council (NRC), PhD
Lakshmi Krishnan was appointed as the Vice President of Life Sciences on a continuing basis as of April 1, 2022 after recently acting in the position. In this capacity, she oversees the Human Health Therapeutics, Aquatic and Crop Resource Development and Medical Devices research centres. As... Read More →

Tuesday November 23, 2021 4:30pm - 6:00pm EST
Virtual
  Science Innovation and Economic Development, Concurrent

Attendees (19)